Dr. Chakri Inampudi, MD

Dr. Inampudi practices at Providence Alaska Medical Center in Anchorage, Alaska, part of Providence Health & Services.

Dr. Inampudi's NPI, 1245226182, was assigned on September 26, 2005. Dr. Inampudi holds Alaska license 4247.

Dr. Inampudi's primary practice is Providence Alaska Medical Center, at 3200 Providence Drive, Anchorage, AK 99508 in Anchorage Borough. The practice phone is (907) 562-2211.

Dr. Inampudi's primary practice is Providence Alaska Medical Center in Anchorage, Alaska, part of Providence Health & Services. Dr. Inampudi is also affiliated with Providence Kodiak Island Medical Center. The medical group on file is Alaska Native Medical Center. Dmand AI also links Dr. Inampudi to 1 more hospital, 3 group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Inampudi practices, 6 sites in all. Vendor and product names are available with a free account.

Diagnostic radiology is Dr. Inampudi's primary specialty in the NPI Registry, under taxonomy code 2085R0202X. Dr. Inampudi is licensed in Alaska.

CMS data shows 5,643 Medicare services from Dr. Inampudi across 31 procedure codes in 2024, for 1,074 Medicare patients. Medicare paid $143,051 for them.

CMS counts 1,074 Medicare patients who saw Dr. Inampudi in 2024. The largest group is 65 to 74, with 495 patients. 75% of them have high blood pressure, and 71% have high cholesterol. 31% are also on Medicaid. Their average risk score is 2.50, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Inampudi's median patient age at 72, with 41% women.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Inampudi for performance year 2024, reported individually. Dr. Inampudi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 123 general payments to Dr. Inampudi from 24 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 82% of the total. Medtronic, Inc. paid the most, $2,029.